SuperworthCRA International CRAI
- Market cap
- $1.3B
- PE
- 26.6×
- 10y median 21.9×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.6×
- EV/EBIT
- 18.0×
- Revenue, 12 months
- $794.6M
- +11% on a year ago
- Net margin
- 6.2%
- Free cash flow yield
- −2.2%
CRA International trades at 26.6× trailing earnings, pricier than 72% of the last ten years. Revenue was $794.6M over the last twelve months, up 11% on a year earlier with a 6% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $147.6M−1% | $161.6M+12% | $171.8M+12% | $171.4M+6% | $167.7M+14% | $176.4M+9% | $181.9M+6% | $186.9M+9% | $185.9M+11% | $197M+12% | $201M+11% | $210.8M+13% | |
| Cost of revenue | $105.9M+4% | $112.7M+12% | $118.9M+10% | $125.3M+11% | $115.2M+9% | $120.5M+7% | $120.4M+1% | $128.5M+3% | $131.5M+14% | $138.9M+15% | $145M+21% | $148.7M+16% |
| Gross profit | $41.7M−10% | $48.9M+10% | $52.9M+18% | $46.1M−5% | $52.6M+26% | $55.9M+14% | $61.5M+16% | $58.3M+27% | $54.4M+4% | $58M+4% | $55.9M−9% | $62.1M+6% |
| SG&A | $27.9M−1% | $29M+3% | $30.5M+8% | $32M+7% | $31.3M+12% | $31.3M+8% | $32.5M+7% | $35.1M+10% | $33.7M+8% | $33.7M+8% | $34.5M+6% | $35.3M+1% |
| $10.8M−28% | $17.1M+29% | $19.6M+43% | $11.3M−29% | $18.4M+70% | $21.5M+25% | $25.5M+30% | $19.7M+75% | $17.2M−6% | $20.6M−4% | $18M−29% | $23.5M+19% | |
| Interest expense | $1M+54% | $600K+24% | $464K−19% | $1.5M−8% | $1.5M+42% | $1M+69% | $429K−8% | $1.8M+21% | $1.8M+20% | $1.4M+37% | $1M+136% | $3M+65% |
| Pre-tax income | $10.5M−34% | $15.6M+40% | $19M+51% | $9.6M−29% | $16M+52% | $21.6M+39% | $24.6M+30% | $17.1M+78% | $16.2M+1% | $18.6M−14% | $17.4M−29% | $20.1M+18% |
| $1.9M−52% | $4.1M+66% | $5.3M+45% | $3.1M−25% | $4.6M+138% | $6.6M+61% | $6.6M+25% | $5M+62% | $4.8M+3% | $5.4M−18% | $6.3M−6% | $6.6M+32% | |
| Net income | $8.6M−28% | $11.5M+32% | $13.7M+54% | $6.5M−31% | $11.4M+33% | $15M+31% | $18M+32% | $12.1M+85% | $11.5M+0% | $13.2M−12% | $11.1M−38% | $13.5M+11% |
| $1.21−26% | $1.62+36% | $1.95+59% | $0.94−30% | $1.67+38% | $2.18+35% | $2.62+34% | $1.79+90% | $1.73+4% | $1.99−9% | $1.69−36% | $2.10+17% | |
| 7.1M−2% | 7.1M−3% | 7M−3% | 6.9M−2% | 6.8M−3% | 6.9M−3% | 6.9M−2% | 6.8M−2% | 6.6M−3% | 6.6M−4% | 6.6M−4% | 6.4M−5% |
Revenue: Q1 FY11: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY11: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY11: 6 months less the 3 months printed beside them. 36 periods, Q3 FY17 to Q2 FY26: not printed by the filing, worked out from its own lines.
SG&A: Q1 FY11: 6 months less the 3 months printed beside them.
Operating income: Q1 FY11: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY11: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY11: 6 months less the 3 months printed beside them.
Income tax: Q1 FY11: 6 months less the 3 months printed beside them.
Net income: Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 11 periods, Q1 FY11 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 9 periods, Q4 FY11 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Specialty Business Services nearest CRA International's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CRAICRA International | $1.3B | 26.6× | 21.9× | 1.6× | +11% | 6.2% | |
| DFINDonnelley Financial Solutions | $1.4B | 38.3× | 18.8× | 1.8× | +3% | 4.5% | |
| VVXV2X | $2.3B | 25.5× | 14.9× | 0.5× | +13% | 1.9% | |
| MHMcGraw Hill | $2.8B | 29.2× | 28.6× | 1.3× | +0% | 4.4% | |
| FCFranklin Covey | $211M | 110× | 34.8× | 0.8× | −6% | 0.8% | |
| Peer median | $1.8B | 33.8× | 23.7× | 1.1× | +2% | 3.1% |
More on CRA International
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 14Specialty Business Services stocks with the fastest revenue growth
- #5of 14Specialty Business Services stocks with the highest profit margins
- #8of 14Specialty Business Services stocks with the lowest price to sales ratio
- #7of 11Specialty Business Services stocks with the lowest EV/EBIT
Its groups
About
- Industry
- Specialty Business Services
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .